M&A TRANSACTION · 2025
OPKO / BioReference Health (Clinical Diagnostics Business) acquired by Labcorp
$192.5M· Laboratory Services
Target
OPKO / BioReference Health (Clinical Diagnostics Business)
OPKO / BioReference Health (Clinical Diagnostics Business) acquisition profile →Disclosed financials at time of acquisition
Revenue
$92.5M
EBITDA
-
Deal Value
$192.5M
What's your laboratory services worth today?
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Context
This $192.5M acquisition of OPKO / BioReference Health (Clinical Diagnostics Business) by Labcorp sits in the laboratory services sub-vertical. Run a valuation for your own laboratory services business via our Laboratory Services valuation hub. Labcorp is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.
Source
Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own laboratory services
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Compare your business to the OPKO / BioReference Health (Clinical Diagnostics Business) acquisition.
More on laboratory services valuations
- Value a laboratory services· run the calculator
- Laboratory Services median multiples· real-deal benchmarks
- Who buys laboratory services businesses?· active buyers
- Who acquired GeneSeek (Neogen Animal Genomics)?· buyer profile
- How to value a laboratory services· long-form guide